The Cooper Companies, Inc.
The Cooper Companies, Inc.
Your view on COO
Overview
What the company does, where it operates, and who runs it.
About The Cooper Companies, Inc.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Albert G. White III
- Headquarters
- 6101 Bollinger Canyon Road, San Ramon, CA, US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Albert G. White III
- Headquarters
- 6101 Bollinger Canyon Road, San Ramon, CA, US
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide.
It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing.
The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for The Cooper Companies, Inc. from FRC's valuation model, read against the market price. COO last traded at $61.88, 21.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for The Cooper Companies, Inc.. Starting points for The Cooper Companies, Inc.: P/E 21.2, EPS $2.95, beta 0.82 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for The Cooper Companies, Inc.. The Cooper Companies, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for The Cooper Companies, Inc.. Trailing twelve-month EPS for The Cooper Companies, Inc. stands at $2.95. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$65.11
average of 9 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy5
- Hold9
- Sell1
- Strong Sell0
Earnings Estimate
| EPS | Current QtrOct 2026 | Next QtrJan 2027 | Current YearFY Oct 2026 | Next YearFY Oct 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.07 | $1.10 | $4.53 | $4.68 |
| Low estimate | $1.06 | $1.06 | $4.52 | $4.54 |
| High estimate | $1.09 | $1.11 | $4.54 | $4.87 |
| No. of analysts | 11 | 7 | 11 | 11 |
| Year-ago EPS | $1.15 | $1.10 | $1.871 | — |
| Growth | -7.1% | -0.4% | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrOct 2026 | Next QtrJan 2027 | Current YearFY Oct 2026 | Next YearFY Oct 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.07B | $1.05B | $4.24B | $4.41B |
| Low estimate | $1.05B | $1.03B | $4.18B | $4.36B |
| High estimate | $1.08B | $1.07B | $4.25B | $4.45B |
| No. of analysts | 10 | 5 | 13 | 13 |
| Year-ago revenue | $1.07B | $1.02B | $4.09B | — |
| Growth | +0.3% | +2.7% | +3.6% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for The Cooper Companies, Inc.. The Cooper Companies, Inc. has reported as a listed company since 1983. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- ALCAlcon Inc.Medical - Specialties$35.4B
- BLCOBausch + Lomb CorporationMedical - Instruments & Supplies$7.5B
- ESLOYEssilorLuxottica S.A.Medical - Instruments & Supplies$129.8B
- GKOSGlaukos CorporationMedical - Devices$14.5B
- HOCPFHOYA CorporationMedical - Instruments & Supplies$64.6B
- LNSRLENSAR, Inc.Medical - Devices$65M
- STAASTAAR Surgical CompanyMedical - Instruments & Supplies$1.3B
More Medical - Instruments & Supplies companies
- MHUAFMeihua International Medical Technologies Co., Ltd.OTC$6M
- MLSSMilestone Scientific Inc.AMEX$27M
- MMSIMerit Medical Systems, Inc.NASDAQ$5.2B
- NAN.AXNanosonics LimitedASX
- NEPHNephros, Inc.NASDAQ$33M
- NNCSFNanosonics LimitedOTC$698M
- NNNNAnbio Biotechnology Class A Ordinary SharesNASDAQ$170M
- NPRRFNipro CorporationOTC$1.3B
- NVSTEnvista Holdings CorpNYSE$3.9B
- NXGLNEXGEL, Inc.NASDAQ$2M
- NXGLWNEXGEL, Inc.NASDAQ$504,035
- OJSYOJsys, Inc.OTC$454,285
ETFs holding The Cooper Companies, Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.02%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.02%
- VBVanguard Small-Cap ETF$76.9B in assets0.14%
- RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.19%
- EQTYKovitz Core Equity ETF$1.4B in assets2.50%
- FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets1.98%
- BASVBrown Advisory Sustainable Value ETF$434M in assets1.91%
- SMOTVanEck Morningstar SMID Moat ETF$327M in assets1.16%
Largest holders first, then the funds most concentrated in COO.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold The Cooper Companies, Inc., and how their positions are changing. At a $11.77B market value, institutional positions materially move The Cooper Companies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by The Cooper Companies, Inc. executives and directors. Shares of The Cooper Companies, Inc. have traded between $61.78 and $106.63 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming The Cooper Companies, Inc.. The Cooper Companies, Inc. is a $11.77B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming The Cooper Companies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for The Cooper Companies, Inc.. Coverage tracks The Cooper Companies, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of The Cooper Companies, Inc.